Effects and recovery from daily and alternate-day instillation of various low-dose atropine eye drops
Effects on pupil size and recovery from daily and alternate-day instillation of various low-dose atropine eye drops in adults with healthy vision
UNSW Sydney
30 participants
Mar 15, 2021
Interventional
Conditions
Summary
Atropine eye drops are known to affect pupil reactions and the ability of the eyes to focus on near objects. This study will quantify the effects of different concentrations of atropine eye drops on these ocular structures when given daily or in an alternate day dosing schedule.
Eligibility
Inclusion Criteria4
- Normal general and ocular health
- Adults aged 18-40 years
- No allergy to atropine or preservatives
- No history or risk of glaucoma
Exclusion Criteria7
- Atropine eye drop use within 2 weeks prior to enrolment
- Any eye diseases including inflammation, infection or allergy
- History of allergic reaction to eye medications
- Risk of glaucoma
- Currently using any eye medications or systemic monoamine oxidase inhibitors (MAOIs)
- Women who are pregnant, planning to become pregnant or breastfeeding\
- History of cardiac disease
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Arm 1: Drug Name: Atropine Sulphate Dose: 1 drop of 0.01% atropine sulphate eye drops in each eye Duration: Daily instillation for 7 days (7 doses) in one eye, every other day instillation for 7 days (4 doses) in fellow eye Mode of administration: Topical eye drop instilled directly by subject before bed Adherence Monitoring: Participant compliance diary Arm 2: Drug Name: Atropine Sulphate Dose: 1 drop of 0.05% atropine sulphate eye drops in each eye Duration: Daily instillation for 7 days (7 doses) in one eye, every other day instillation for 7 days (4 doses) in fellow eye Mode of administration: Topical eye drop instilled directly by subject before bed Adherence Monitoring: Participant compliance diary
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12621000233820